| |
|
|
|
|
|
|
|||
|
Blood, 1 November 2008, Vol. 112, No. 9, pp. 3704-3712. Prepublished online as a Blood First Edition Paper on August 8, 2008; DOI 10.1182/blood-2008-06-160945.
Submitted June 3, 2008
Biological Sciences, University of California, San Diego, La Jolla, CA, United States * Corresponding author; email: agoldrath{at}ucsd.edu.
While it is known that interleukin (IL)-7 and IL-15 influence the survival and turnover of CD8+ T cells, less is known about how these cytokines affect different subsets of CD8+ T cells during the course of the immune response. We find that IL-7 and IL-15 differentially regulate CD8+ T cell subsets defined by KLRG1 and CD127 expression during the contraction phase of the immune response. The provision of IL-15, or the related cytokine IL-2, during contraction, led to the preferential accumulation of KLRG1hiCD127lo CD8+ T cells, while provision of IL-7 instead favored the accumulation of KLRG1loCD127hi. Interestingly, while both IL-7 and IL-15 induced proliferation of KLRG1lo CD8+ T cells, KLRG1hi cells exhibited an extraordinarily high level of resistance to cytokine-driven proliferation in vivo despite their dramatic accumulation upon IL-15 administration. These results suggest that IL-15 and IL-2 greatly improve the survival of KLRG1hi CD8+ T cells, which are usually destined to perish during contraction, in the absence of proliferation. As the availability of IL-15 and IL-2 is enhanced during periods of extended inflammation, our results suggest a mechanism where a population of cytokine-dependent KLRG1hi CD8+ T cells is temporarily retained for improved immunity. Consideration of these findings may aid in the development of therapies for augmenting T cell-directed immunotherapeutic strategies against infectious disease and cancer.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||